Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
| Actual shortage: | 232 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NAPROXEN | 250MG | TABLET | Resolved | 2018-02-01 | 2018-04-05 | 37971 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2018-02-01 | 2018-04-15 | 37989 |
| APO-CEFUROXIME | 250MG | TABLET | Resolved | 2018-02-05 | 2018-04-14 | 38505 |
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2018-02-21 | 2018-05-01 | 40351 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-03-05 | 2018-06-08 | 41852 |
| APO-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Resolved | 2018-03-13 | 2018-07-03 | 42717 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2018-03-27 | 2018-04-24 | 44099 |
| APO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2018-05-08 | 2018-09-11 | 48841 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2018-05-15 | 2019-02-21 | 49481 |
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2018-07-04 | 2018-12-28 | 54297 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2018-07-11 | 2018-08-09 | 55276 |
| APO-NAPROXEN | 250MG | TABLET | Resolved | 2018-08-09 | 2018-10-26 | 57799 |
| APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2018-08-27 | 2019-01-02 | 59292 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2018-09-04 | 2018-12-18 | 59816 |
| APO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2018-10-11 | 2019-06-08 | 63796 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-10-19 | 2019-01-10 | 64938 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2018-11-16 | 2019-01-17 | 67034 |
| APO-NAPROXEN | 250MG | TABLET | Resolved | 2018-12-12 | 2018-12-21 | 69305 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2019-01-03 | 2019-02-01 | 71103 |
| APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2019-02-13 | 2019-02-21 | 75617 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
| APO-DILTIAZ TZ | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1064 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |